AI assistant
Sending…
MYRIAD GENETICS INC — Director's Dealing 2010
Feb 19, 2010
32566_dirs_2010-02-19_b98325e4-5718-477f-8ec1-7ad2dfe14ac4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2010-02-18
Reporting Person: Capone Mark Christopher (Chief Operating Officer, MGL)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-02-18 | Common Stock | M | 5000 | $7.27 | Acquired | 40454 | Direct |
| 2010-02-18 | Common Stock | M | 2000 | $8.63 | Acquired | 42454 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-02-18 | Incentive Stock Option (right to buy) | $7.27 | M | 5000 | Disposed | 2015-09-14 | Common Stock (5000) | Direct |
| 2010-02-18 | Incentive Stock Option (right to buy) | $8.63 | M | 2000 | Disposed | 2016-02-16 | Common Stock (2000) | Direct |
Footnotes
F1: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.
More from MYRIAD GENETICS INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Regulatory Filings
2026
Jun 4
Share Issue/Capital Change
2026
Jun 4
Interim / Quarterly Report
2026
May 6
Report Publication Announcement
2026
May 5
Annual Report
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Major Shareholding Notification
2026
Apr 7
Major Shareholding Notification
2026
Mar 27